https://www.taxtmi.com/news?id=47005 A strategic Letter of Intent between Miltenyi Biotec India and BIRAC sets a framework to develop India's Cell and Gene Therapy ecosystem by implementing structured training for CGT manufacturing and quality control, co developing translational and multi center clinical research for next generation therapies, and establishing Point of Care CAR T centers using automated platforms like CliniMACS Prodigy to scale decentralized manufacturing and support local innovation. en-us Thu, 19 Jun 2025 10:16:02 +0530 Thu, 19 Jun 2025 10:16:02 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=47005 A strategic Letter of Intent between Miltenyi Biotec India and BIRAC sets a framework to develop India's Cell and Gene Therapy ecosystem by implementing structured training for CGT manufacturing and quality control, co developing translational and multi center clinical research for next generation therapies, and establishing Point of Care CAR T centers using automated platforms like CliniMACS Prodigy to scale decentralized manufacturing and support local innovation. News - Thu, 19 Jun 2025 10:16:02 +0530 https://www.taxtmi.com/news?id=47005